Sitagil DM (Dapagliflozin, Sitagliflozin & Metformin Hydrochloride (ER) (10/100/500))

Sitagil DM combines Dapagliflozin, Sitagliptin, and Metformin Hydrochloride (ER) in a potent formulation designed for effective management of type 2 diabetes mellitus. Dapagliflozin promotes the excretion of excess glucose through the kidneys, Sitagliptin enhances insulin secretion and reduces glucose production in the liver, while Metformin improves insulin sensitivity and decreases hepatic glucose output. This comprehensive approach aids in optimal blood sugar control, improves glycemic levels, and reduces the risk of diabetes-related complications.